Genentech has announced positive, top line results from a Phase 2 study of its Port Delivery System (PDS) with Lucentis in people with wet age-related macular degeneration (AMD). The small, refillable eye implant, which is slightly longer than a grain of rice, is designed to allow people with wet AMD to go several months without […]
Allergan and Molecular Partners have announced the release of two positive clinical trials of a new treatment for wet age-related macular degeneration (wAMD). The trials, named SEQUOIA and CEDAR, demonstrated that the biological drug Abicipar is equal to Genentech’s Lucentis (ranibizumab), with the added benefit that Abicipar treatments are effective at up to 12-week dosages. […]
The drug Emixustat has been in Phase 1/2 trials since 2008 for treatment of dry macular degeneration. Disappointingly, the drug has now been found to be ineffective at reducing the growth rates of geographic atrophy (GA) in patients with age-related macular degeneration (AMD). Preclinical analysis of Emixustat indicated that it inhibited the activity of the […]
Age-related macular degeneration (AMD) is the most common cause of visual impairment in people over age 60. Because it affects millions of senior adults, it deserves a great deal of attention. Another common condition also deserving of consideration is dry eye. Dry eye often accompanies AMD, but only because it most commonly affects the same […]
Prevent Blindness wants all Americans to know that 14% of all injuries from fireworks are to the eyes, and that contusions, lacerations, and foreign bodies in the eyes occurred more frequently than burns to other parts of the body. Here are more important statistics from the U.S. Consumer Product Safety Commission: Fireworks devices were involved […]
Transcript of a presentation to the International Low Vision Support Group June 2018 Dan Roberts, Director Select this link for audio-visual format INTRODUCTION This is our 13th annual summary of leading research and developments occuring during the past 12 months in the fields of blindness and low vision. Sources for further information will appear beneath […]
by Dan Roberts What do these six famous people have in common? They are all different in many ways, but they each possess at least one characteristic which sets them apart. They have a strong sense of empathy, making it impossible for them to remain silent in the face of […]
Degeneration of photoreceptors (rod and cone cells) is a leading cause of vision loss. Since there are no effective treatments to restore vision once photoreceptors are lost, photoreceptor regeneration has the very real prospect of alleviating blindness in these eyes. To that end, a recent innovative study has demonstrated the possibility of reprogramming Müller glial […]
Studies in France and the Netherlands have shown that a Mediterranean diet is linked to a lower risk of age-related macular degeneration (AMD). Researchers investigated the effects of such a diet on a large sample from subjects from two population-based prospective studies. The diet consists of more than median intakes of vegetables, fruits, legumes, cereals, […]
One of the frustrations of visual impairment is the difficulty of explaining our vision to others. We often hear things like, “How did you see that? I thought you were blind!” Another issue we deal with is how to personally keep track of our vision changes throughout the progression of our disease. Our eye doctors have […]